Welcome to our dedicated page for Herbalife news (Ticker: HLF), a resource for investors and traders seeking the latest updates and insights on Herbalife stock.
Herbalife Ltd (HLF) is a global leader in nutrition solutions and direct-selling innovation, serving millions through science-backed products and community-driven distribution. This page aggregates all material developments impacting HLF's market position and operational strategy.
Investors and industry observers will find verified press releases, earnings call transcripts, regulatory disclosures, and analysis of strategic initiatives. Content spans product innovations, partnership announcements, financial performance metrics, and leadership updates critical for evaluating HLF's trajectory.
The repository is maintained to professional standards, prioritizing timeliness and accuracy while avoiding speculative commentary. Users can expect coverage of weight management sector trends, direct-selling regulatory changes, and Herbalife's responses to evolving consumer health demands.
Bookmark this page for streamlined monitoring of HLF's corporate communications and market-moving developments. Combine these primary sources with Stock Titan's analytical tools for comprehensive investment research.
Herbalife Nutrition Ltd. (NYSE: HLF) will announce its second quarter 2022 financial results on
Herbalife Nutrition has announced plans to consolidate its corporate headquarters and North American operations into a single campus in Los Angeles. This strategic move aims to foster collaboration by bringing together its workforce, enhancing company culture. The company will vacate its downtown office at LA Live and relocate employees to an owned office building nearby. Upgrades to the new campus are already underway, with completion expected by the end of 2023. This development will also serve as a meeting point for local distributors and global leadership.
Herbalife Nutrition has announced a
The Herbalife Nutrition Foundation has launched a two-year partnership with The Power of Nutrition and the World Bank, initiating a $300,000 grant focused on reducing stunting in Rwanda. This program aims to improve nutrition for over one million women and children in the region, addressing the alarming stunting rate of 33% in children under five. Funding will support essential nutrition services and cash transfers for better diets. The partnership aligns with the United Nations Sustainable Development Goal to achieve zero hunger globally.
Herbalife Nutrition (NYSE: HLF) announced that its executives will present at three financial conferences in June 2022. Key speakers include
Herbalife Nutrition Ltd. (NYSE: HLF) reported Q1 2022 financial results, showing net sales of $1.3 billion, an 11% decline from Q1 2021. Reported diluted EPS was $0.96, down from $1.33 a year earlier. Despite a 7% drop in volume points, the company expects a turnaround in net sales by Q4 2022, aided by in-person sales events and new initiatives. Adjusted EBITDA reached $185.6 million, just above guidance. Full-year sales guidance has been lowered to a range of down 10% to down 4%. The company is implementing pricing and cost measures in response to inflationary pressures.
Herbalife Nutrition has achieved the North Carolina Department of Labor Silver Award for the 6th year and its first Gold Award, recognizing its commitment to safety at its Winston-Salem facility. This facility, which opened in 2014, spans 800,000 square feet and produces around 400,000 units daily. Additionally, Herbalife holds ISO certifications for health and safety standards, further demonstrating its dedication to employee welfare. The company operates five manufacturing facilities globally and emphasizes quality control through its accredited laboratories.
Herbalife Nutrition (NYSE: HLF) has nominated Celine Del Genes to its Board of Directors ahead of the Annual General Meeting. Del Genes, currently the Global General Manager at adidas AG, brings over 20 years of marketing and business leadership experience. CEO John Agwunobi believes her expertise will significantly enhance the Board's capabilities and drive future growth for the company. With this nomination, Herbalife's Board will consist of 11 directors, emphasizing diversity. Del Genes is expected to leverage her experience to create greater shareholder value.